Scil Technology develops unique biomaterials that integrate bone or cartilage growth factors and synthetic scaffolds or implants. Applying its proprietary technology, the Company combines the very best of prosthetic and bone augmentation technologies with pioneering regenerative medicine. What sets Scil Technology further apart is its proprietary protein coating technology that allows for a highly stable and homogeneous bonding of growth factors to scaffolds or implants. Scil Technology is using this expertise to develop applications for dentistry and orthopaedics.